Breast cancer is considered a fatal disease and is known as the leading cause of cancer death in women. According to the American Cancer Society, CA 1st 3 million new cases of breast cancer on a basis which includes diagnosed each year 465,000 deaths. To effectively fight against this devastating disease, we must encourage innovative scientists to study cancer at its lowest level. In other words, the research of breast cancer will be conducted at its molecular level. Furthermore, in addition to governments, private organizations are flexible funding to scientists who conduct research on breast cancer. Adequate funding for research on breast cancer that can not only lead to better prevention strategies, but it may contribute to the time of diagnostic techniques and new drugs and therapies against cancer. A world renowned cancer researcher named Lothar Hirneise came to the idea that cancer with stress that is. He believes that if the mind under constant stress, the body then produces high levels of cortisol stress hormone. The immune system is depressed with a high cortisol in the body. It also stresses a spirit Adrenaline release out to a degree of exhaustion. People with cancer, found that little adrenaline in their cells. In fact, cells of cancer patients are often overloaded with insulin and sugar. A leading German cancer researcher with the name “Ryke Geerd Hamer has over twenty thousand cancer patients and found a direct correlation between psycho-emotional conflict or cancer patients. The operation lasts between 1 to 3 years before cancer diagnosis and training in the body. Cancer patients who have undergone a psycho – emotional conflicts, etc., as the loss of a loved one, a few years before his urine cancer, experienced pain and emotional stress in itself. Such a state of mind may have a negative effect on the immune system of human body. “ve Recently, researchers working for the research of breast cancer, developed and tested successfully in Vaccine for breast cancer is likely to treat women with treatment – resistant HER2 – breast cancer and therefore able to prevent cancer – accident. research on breast cancer are eager to use vaccines DNA against cancer HER2 – a free woman to prevent the initial development of these tumors. Currently, therapies such as trastuzumab and lapatimib to treat patients with breast cancer used. However, it has been noticed recently that encourage large group of patients develop resistance to trastuzumab and lapatimib. HER2 are known for a particular type of tumor that affects about thirty per cent of all patients with breast cancer. The new vaccine for breast cancer is produced by specific cells agency. It offers an anti-cancer gene in cells that then destroy the immune system proteins but also tumor – cells. According to lead investigator, Wei – Zen Wei, professor of immunology and microbiology at ‘Karmanos Cancer Institute, the vaccine has been involved with it – in the form of naked DNA from genes that produce the HER2 protein. DNA introduced with an immune stimulant. The process for manufacturing the vaccine, which is called electroporation. In this process, electrical impulses were used for the injected vaccine into leg muscles in mice. Genes, moved to the cell, which then produces the HER2 receptor, which leads to activation of antibodies and immune cells, killer T cells. This vaccine is unique and much more research is also needed so that he could one day be in people for the processing of the application of breast cancer .
You must be logged in to post a comment.
